Apellis Pharmaceuticals Inc (APLS) USD0.0001
0.30%- This stock can be held in a
Stocks and Shares ISASell:$37.35
Buy:$37.41
Change:
$0.25
(0.66%)
$0.25
(0.66%)Prices delayed by at least 15 minutes
Sell:$37.35
Buy:$37.41
Change:$0.25
(0.66%)
$0.25
(0.66%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 21 June 2024 | EPIDAREX CAPITAL PARTNERS LLCVenture Capital | Sell Regular sell transaction (market) | 35,305 | $39.22 | $1,384,662.10 | 138,693 |
| 21 June 2024 | EPIDAREX CAPITAL PARTNERS LLCVenture Capital | Sell Regular sell transaction (market) | 1,695 | $39.63 | $67,172.85 | 136,998 |
| 8 May 2024 | Pascal DeschateletsPresident | Sell Option/Award related | 56,335 | $42.15 | $2,374,542.78 | 1,138,555 |
| 8 May 2024 | Pascal DeschateletsPresident | Sell Option/Award related | 22,472 | $42.85 | $962,902.73 | 1,116,083 |
| 8 May 2024 | Pascal DeschateletsPresident | Sell Option/Award related | 100 | $44.03 | $4,402.50 | 1,115,983 |
| 8 April 2024 | Pascal DeschateletsPresident | Sell Option/Award related | 64,379 | $54.12 | $3,483,966.15 | 1,120,711 |
| 8 April 2024 | Pascal DeschateletsPresident | Sell Option/Award related | 4,728 | $54.92 | $259,639.07 | 1,115,983 |
| 1 April 2024 | Timothy Eugene (Tim) SullivanCFO | Sell Option/Award related | 4,000 | $58.66 | $234,640.00 | 93,338 |
| 19 March 2024 | EPIDAREX CAPITAL PARTNERS LLCVenture Capital | Sell Regular sell transaction (market) | 18,681 | $57.18 | $1,068,160.90 | 173,998 |
| 18 March 2024 | Mark Jeffrey DeLongChief Level Officer | Sell Regular sell transaction (market) | 9,913 | $56.90 | $564,049.70 | 54,693 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 1 March 2024 | Cedric G FrancoisChairman/CEO | Sell Option/Award related | 116,512 | $64.92 | $7,563,527.95 | 314,075 |
| 1 September 2023 | Cedric G FrancoisChairman/CEO | Sell Tax related | 139,716 | $41.70 | $5,826,506.49 | 434,939 |
| 1 December 2023 | Adam J TownsendChief Level Officer | Sell Option/Award related | 67,557 | $60.50 | $4,087,326.86 | 118,850 |
| 1 March 2024 | Cedric G FrancoisChairman/CEO | Sell Option/Award related | 62,503 | $64.26 | $4,016,274.02 | 430,587 |
| 8 April 2024 | Pascal DeschateletsPresident | Sell Option/Award related | 64,379 | $54.12 | $3,483,966.15 | 1,120,711 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.